Davronova Khilola Zavkiddinovna (1)
Cerebrovascular disease, blood circulation disorder in the brain is one of the most important medical and social problems, and it takes the leading place in terms of morbidity and mortality of the population. In addition, it is characterized by a high mortality rate and is considered one of the main causes of permanent disability. Chronic TsVK is considered an important risk factor for the development of ischemic stroke and is accompanied by neurological and mental disorders(ФединА.И.,2015). There are many scientific studies focused on diabetes and acute cerebral hemostasis. Nevertheless, chronic forms of TsVK have been studied very little. The pathogenesis of DM is mainly determined by the increased risk of atherosclerosis, cerebral angiopathy and cognitive impairment.
1. Abbatecola A.M., Rizzo M.R., Barbieri M. et al. Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics // Neurology, 2006. – V. 67. – P. 235–240.
2. Alafuzoff I., Aho L., Helisalmi S. et al. β-Amyloid deposition in brains of subjects with diabetes // Neuropathol. Appl. Neurobiol., 2009. – V. 35. –P. 60–68.
3. Arvanitakis Z. et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons // Neurology, 2006. – V. 67. – P. 1960–1965.
4. Beeri M. et al. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology // Neurology, 2008. – V. 71. – P. 750–757.
5. Biessels G.J., Staekenborg S., Brunner E., et al. Risk of dementia in diabetes mellitus: a systematic review // Lancet Neurol., 2006. – V. 5. – P. 64–74.
6. Craft S. The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia // Arch. Neurol., 2009. – V. 66. – P. 300–305. 13. DCCT/EDIC Study Recearch Group. Long-Term effect of diabetes and its treatment on cognitive function // New Engl. J. Med., 2007. – V. 356. – Р. 1842–1852.
7. Irie F., Fitzpatrick A.L., Lopez O.L. Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE-4 // Arch. Neurol., 2008. – V.65. – P. 89–93.
8. Kalaria R.N. Diabetes, microvascular pathology and Alzheimer disease // Nature Rev. Neurology, 2009. – V. 5. – P. 305–306.
9. Рахматова, Д. И., & Пулатов, С. С. (2016). Особенности течения инволюционной эпилепсии. Биология и интегративная медицина, (1), 70-82.
10. Ismatilloyevna, R. D. (2022). The effectiveness of neuroprotective therapy in ischemic stroke. European journal of modern medicine and practice, 2(1), 17-21.
11. Рахматова, Д. И. (2019). Нетрадиционные методы терапии невропатии лицевого нерва на разных этапах развития заболевания. Проблемы биологии и медицины, 2(107), 180-183.
12. Рахматова, Д. И. (2022). Новые Возможности Оценки Лечения У Больных С Невропатией Лицевого Нерва Коморбидных С Сахарным Диабетом. AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI, 1(7), 38-43.
13. Рахматова, Д. И. (2021). ЗНАЧЕНИЕ НЕЙРОВИЗУАЛИЗАЦИОННОГО МЕТОДА ИСЛЛЕДОВАНИЯ В ДИАГНОСТИКЕ ОСЛОЖНЁННЫХ ФОРМ НЕВРОПАТИИ ЛИЦЕВОГО НЕРВА. ЖУРНАЛ НЕВРОЛОГИИ И НЕЙРОХИРУРГИЧЕСКИХ ИССЛЕДОВАНИЙ, 2(3).
14. Саломова, Н. К. (2021). Особенности течения и клинико-патогенетическая характеристика первичных и повторных инсультов. Central Asian Journal of Medical and Natural Science, 249-253.
15. Саломова, Н. Қ. (2023). ҚАЙТА ИШЕМИК ИНСУЛЬТЛАРНИНГ КЛИНИК ПОТОГЕНИТИК ХУСУСИЯТЛАРИНИ АНИҚЛАШ. Innovations in Technology and Science Education, 2(8), 1255-1264.
16. Рахматова, Д. И., & Саломова, Н. К. НОВЫЙ ДЕНЬ В МЕДИЦИНЕ. НОВЫЙ ДЕНЬ В МЕДИЦИНЕ Учредители: Бухарский государственный медицинский институт, ООО" Новый день в медицине", (1), 225-229.
17. Salomova, N. K. (2022). Risk factors for recurrent stroke. Polish journal of science N, 52, 33-35.
18. Qahharovna, S. N. (2023). Thromboocclusive Lesions of the Bronchocephalic Arteries: Treatment Options and Phytotherapy Options. AMERICAN JOURNAL OF SCIENCE AND LEARNING FOR DEVELOPMENT, 2(2), 41-46.
19. Salomova Nilufar Kakhorovna//FEATURES OF NEUROREHABILITATION ITSELF DEPENDING ON THE PATHOGENETIC COURSE OF REPEATED STROKES, LOCALIZATION OF THE STROKE FOCUS AND THE STRUCTURE OF NEUROLOGICAL DEFICIT//European Journal of Research Development and Sustainability (EJRDS 11. 8-12. 2022/11
20. Salomova, N. K. (2022). Risk factors for recurrent stroke. Polish journal of science N, 52, 33-35.
21. Гаффарова В.Ф. Способ прогнозирования психоречевых нарушений при фебрильных судорогах у детей. Методическая рекомендация. 2021.-С.18.
22. Гаффарова В.Ф. Алгоритм ведения детей с фебрильными судорогами с учетом ранней профилактики психо-речевых нарушений.Методическая рекомендация. 2021.-С.18.
23. Гаффарова В.Ф. Болаларда тутқаноқдан кейин психо-лингвистик нутқ бузилишларини аниқлаш. ЭҲМ учун дастур.DGU 20212367.
24. Gaffarova V.F. Мethod for prediction of psycho-speech disorders during febril conversions in children.// (Scopus) 2022 C. 951-955
25. Sadullayev D.I., Gaffarova V.F. Cognitive disorders in patients with acute cerebrovascular accident and arterial hypertension.// Amaliy va tibbiyot fanlar jurnali 2022.-P. 293-295.